Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alt Biotech logo — For a brighter Future

Alt Biotech

For a brighter Future

Founded 2023 France France 1 employees Non Equity Assistance Biopharma, Biotechnology

General Information

Company Name Alt Biotech
Founded Year 2023
Location France France
Employees 1
Industries Biopharma, Biotechnology
Funding Stage Non Equity Assistance
Business Model B2B, B2B2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Alt Biotech. To contact Alt Biotech, visit alt-biotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alt Biotech compare?

A PDF of Alt Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alt Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alt Biotech

Alt Biotech, headquartered in France, was founded in 2023 with a mission encapsulated in their slogan, "For a brighter Future." As a budding player in the Biopharma and Biotechnology industries, the company is focused on pioneering advancements in bioproduction. Their commitment to innovation is evident in their dedication to paving new paths in the sector.

The company made significant strides with a recent Non Equity Assistance investment from AGORANOV on 01 November 2023, reflecting investor confidence in its potential. This involvement underscores Alt Biotech's ability to attract interest from established players within the innovation ecosystem, signaling robust backing for its strategic initiatives.

Given its early stage of development and strategic support from key industry stakeholders, Alt Biotech presents an intriguing opportunity for investors looking to tap into the transformative potential of biotechnological advancements on a global scale.

Business keywords: bioproduction, innovation, future technology, pathway engineering, sustainable production, bioprocessing, bioengineering, synthetic biology, green technology, environmental sustainability, biomanufacturing, bio-based products, industry innovation

Services & Products

analysis of digital communication trends
development of communication strategies
insight into modern relationship dynamics

Target Customers

dating platforms social media companies communication consultants

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
AGORANOV
AGORANOV
01 Nov 2023

Alt Biotech Alternatives & Competitors

View All Alternatives
Alt Biotech vs
MagGenix
MagGenix United States

Transforming Cell Therapeutics Through Magnetic Precision

7 employees
Biopharma, Biotechnology
Alt Biotech vs
Solugen
Solugen United States

Decarbonizing the physical world.

Series D
137 employees
Biopharma, Biotechnology
Alt Biotech vs
Veminsyn
Veminsyn

Innovative chemical production for sustainable beauty and diverse future applications

Series A
Biopharma, Biotechnology
View all alternatives

FAQ About Alt Biotech

For a brighter Future
Alt Biotech was founded in 2023.
Alt Biotech is headquartered in France.
Alt Biotech operates in Biopharma and Biotechnology. Its work centres on bioproduction, innovation, future technology and pathway engineering. Its customers include dating platforms, social media companies and communication consultants.
Alt Biotech has a B2B and B2B2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Alt Biotech has approximately 1 employees.
Alt Biotech has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Alt Biotech offers: analysis of digital communication trends, development of communication strategies, insight into modern relationship dynamics.
Top alternatives and competitors to Alt Biotech include MagGenix, Solugen, Veminsyn, Berkeley Lights, Biosyntia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alt Biotech and MagGenix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alt Biotech, https://bouncewatch.com/company/alt-biotech, updated 23 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes